Recombinant staphylokinase (Shanghai Tonghuayujin)

重组葡激酶(通化玉金药业)

Report date: 2023/05/16 15:07:05

Base Information

Drug NameRecombinant staphylokinase (Shanghai Tonghuayujin)
Drug Alias Name施爱克
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionPlasminogen stimulants
TargetsPlasminogen
Therapy Area/IndicationsIschemic StrokeThromboembolismPulmonary Embolism
Global Approved IndicationsThromboembolism
Approved Indications in ChinaThromboembolism
Original Approved Country/TerritoryMainland China
Original Approved Date2004/09/21
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsIschemic StrokeThromboembolismPulmonary Embolism
Inactive IndicationsN/A

Other Information

ATC CodeB01AD
Related LinksN/A